We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+15.34%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$338M
AUM Growth
+$65.4M
(+24%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
13.18%
Top 10 Holdings %
Top 10 Hldgs %
27.92%
Holding
106
New
39
Increased
24
Reduced
12
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.7M |
| 2 |
GSK
GSK
|
+$7.94M |
| 3 |
Centene
CNC
|
+$7.26M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$6.94M |
| 5 |
SHPG
Shire pic
SHPG
|
+$6.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$9.99M |
| 2 |
iShares Europe ETF
IEV
|
+$7.22M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
+$7.07M |
| 4 |
Humana
HUM
|
+$6.83M |
| 5 |
AET
Aetna Inc
AET
|
+$4.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.98% |
| 2 | Financials | 0% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $11.8M | 3.49% |
50,000
-37,500
| -43% | -$8.71M |
|
|
HOLX
2
DELISTED
Hologic
HOLX
| $10.7M | 3.18% |
252,500
+38,075
| +18% | +$1.55M |
|
3
Bio-Rad Laboratories Class A
BIO
$8.74B
| $10.6M | 3.12% |
53,000
+22,500
| +74% | +$4.33M |
|
4
Baxter International
BAX
$13.8B
| $9.34M | 2.76% |
180,000
+30,000
| +20% | +$1.48M |
|
|
BCR
5
DELISTED
CR Bard Inc.
BCR
| $9.32M | 2.76% |
37,500
+1,000
| +3% | +$241K |
|
6
Boston Scientific
BSX
$68.4B
| $9.08M | 2.68% |
365,000
-15,000
| -4% | -$365K |
|
|
EVHC
7
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $8.59M | 2.54% |
140,000
-1,644
| -1% | -$110K |
|
8
Globus Medical
GMED
$10.9B
| $8.46M | 2.5% |
285,646
+85,646
| +43% | +$2.34M |
|
|
EXAS
9
DELISTED
Exact Sciences
EXAS
| $8.27M | 2.44% |
+350,000
| New | +$6.94M |
|
|
10
GSK
GSK
$104B
| $8.25M | 2.44% |
+156,500
| New | +$7.94M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.18M | 2.42% |
+67,500
| New | +$8.7M |
|
12
UnitedHealth
UNH
$383B
| $7.79M | 2.3% |
47,500
-15,000
| -24% | -$2.46M |
|
13
CALL
Abbott
ABT
$183B
| $7.77M | 2.3% |
+175,000
| New | +$7.57M |
|
|
14
Centene
CNC
$30.1B
| $7.73M | 2.29% |
+216,982
| New | +$7.26M |
|
15
ICU Medical
ICUI
$4.21B
| $7.63M | 2.26% |
50,000
+27,500
| +122% | +$4.02M |
|
|
NXTM
16
DELISTED
NxStage Medical Inc.
NXTM
| $7.38M | 2.18% |
275,000
+17,500
| +7% | +$483K |
|
17
Revvity
RVTY
$12.7B
| $6.94M | 2.05% |
+119,500
| New | +$6.52M |
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $6.9M | 2.04% |
28,875
+22,175
| +331% | +$5.16M |
|
|
19
Abbott
ABT
$183B
| $6.88M | 2.04% |
+155,000
| New | +$6.7M |
|
20
Universal Health Services
UHS
$9.88B
| $6.84M | 2.02% |
+55,000
| New | +$6.5M |
|
|
SHPG
21
DELISTED
Shire pic
SHPG
| $6.82M | 2.02% |
+39,125
| New | +$6.83M |
|
|
XENT
22
DELISTED
Intersect ENT, Inc
XENT
| $6.65M | 1.97% |
+387,922
| New | +$5.43M |
|
|
IVC
23
DELISTED
Invacare Corporation
IVC
| $6.25M | 1.85% |
525,010
+301,571
| +135% | +$3.62M |
|
24
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
| $6.24M | 1.85% |
100,000
+40,000
| +67% | +$2.44M |
|
25
Teleflex
TFX
$5.86B
| $5.81M | 1.72% |
+30,000
| New | +$5.4M |
|
Similar funds
GMP
BCA
ONGA
RC
CVV
DOFI
SRA
SR
Pura Vida Investments's Q1 2017 Portfolio in Review
As of Q1 2017, Pura Vida Investments held 106 positions worth $338M, up 24% from $273M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Pura Vida Investments deployed $44.6M of net new capital in Q1 2017, opening 39 new positions and adding to 24 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 67,500 shares worth $8.18M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 53% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $4.26M trimmed.
- Pura Vida Investments's largest Q1 2017 buy was Alexion Pharmaceuticals: 67,500 shares worth $8.18M.
- Pura Vida Investments added most to Allergan plc in Q1 2017, an estimated $5.16M increase.
- Pura Vida Investments's biggest Q1 2017 reduction was AbbVie, cutting an estimated $4.26M.
- Pura Vida Investments fully exited Athenahealth, Inc. in Q1 2017, selling an estimated $9.99M.
- Pura Vida Investments's ten largest holdings make up 28% of its $338M portfolio in Q1 2017.
- Pura Vida Investments opened 39 new positions and closed 28 in Q1 2017.
- Pura Vida Investments's portfolio value rose 24% quarter-over-quarter to $338M.
Based on Pura Vida Investments's 13F filing for Q1 2017, filed 15 May 2017.